FDA officials: High-quality data is essential for AI tools for generic drugs
Regulatory NewsJoanne S. Eglovitch
Artificial intelligence/machine learning (AI/ML)GenericsModeling and simulationProduct developmentRegulatory Intelligence/PolicyRegulatory strategyUnited StatesUS Food and Drug Administration (FDA)